ED-B fibronectin as stratification marker for anti-tumor drugs

Details for Australian Patent Application No. 2008300986 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Berndorff, Dietmar; Heinrich, Tobias; Dinkelborg, Ludger

Agent Davies Collison Cave

Pub. Number AU-A-2008300986

PCT Pub. Number WO2009/036885

Priority 07018213.4 17.09.07 EP

Filing date 4 September 2008

Wipo publication date 26 March 2009

International Classifications

A61K 49/00 (2006.01) Preparations for testing

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/036885 Priority application(s): WO2009/036885

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008300996-Compact, flexible CSP facility for continuous, semi-continuous and batch operation

2008300971-Mould for the continuous casting of metal, and process for producing such a mould